Bosnes V, Hirschberg H
Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
J Neurosurg. 1989 Aug;71(2):218-23. doi: 10.3171/jns.1989.71.2.0218.
Tumor-infiltrating lymphocytes (TIL's) were isolated from human glioma biopsy specimens by immunomagnetic separation using T cell-specific monoclonal antibodies coupled to paramagnetic beads, and were expanded in culture with feeder cells and interleukin-2 (IL-2). The infiltrating cells from five of seven patients proliferated in culture. When tested after 2 to 3 weeks of culture, virtually all of the cells stained with antibodies against the CD2 and CD3 antigens. Most cells also expressed human leukocyte antigen class II molecules, while varying percentages of cells stained with antibodies against the IL-2 receptor and the CD4 and CD8 antigens. The cytotoxicity of the cultured TIL's against autologous and allogeneic glioma cells and the K562 and Daudi cell lines was measured and compared with that of lymphokine-activated killer (LAK) cells from the same patients. None of the TIL's showed significant cytotoxicity against these targets, whereas LAK cells lysed all of the targets.
通过使用与顺磁性微珠偶联的T细胞特异性单克隆抗体进行免疫磁分离,从人胶质瘤活检标本中分离出肿瘤浸润淋巴细胞(TIL),并与饲养细胞和白细胞介素-2(IL-2)一起在培养物中扩增。7例患者中有5例的浸润细胞在培养物中增殖。培养2至3周后进行检测时,几乎所有细胞都用抗CD2和CD3抗原的抗体染色。大多数细胞还表达人类白细胞抗原II类分子,而不同百分比的细胞用抗IL-2受体以及CD4和CD8抗原的抗体染色。测量培养的TIL对自体和同种异体胶质瘤细胞以及K562和Daudi细胞系的细胞毒性,并与来自同一患者的淋巴因子激活的杀伤(LAK)细胞的细胞毒性进行比较。没有TIL对这些靶标表现出明显的细胞毒性,而LAK细胞裂解了所有靶标。